Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide mobilization" refers to the process by which nitric oxide (NO)—a short-lived, endogenously produced gaseous molecule— is synthesized primarily by nitric oxide synthase (NOS) enzymes from L-arginine and released into tissues to act as a versatile signaling molecule. NO diffuses freely across membranes, binding to targets such as soluble guanylate cyclase in vascular smooth muscle to produce cGMP and cause vasodilation, inhibits platelet aggregation, and acts as a neurotransmitter and immune effector. It has essential roles in cardiovascular regulation, neurotransmission, and host defense but is not itself a molecular drug target; instead, its pathway components (NOS enzymes, guanylate cyclase) serve as recognized pharmacological targets.
Stimulate guanylate cyclase to increase cGMP, leading to vasodilation. Inhibition of platelet aggregation. Modulation of neuronal transmission through cGMP and S-nitrosylation. Immune cytotoxicity (via macrophage NO production).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide mobilization.